Enpro to acquire Advanced Micro Instruments
AMI to become part of Enpro’s Sealing Technologies Segment
AMI to become part of Enpro’s Sealing Technologies Segment
According to Sun Pharma, the purpose of the strategic investment is to obtain access to the technology for certain compounds and territories while also fostering the development of novel pharmaceutical delivery systems.
The unit’s contribution to the company's revenue US$3.85 million in the last fiscal year
The product is expected to be launched in December 2023
Loteprednol Etabonate Ophthalmic Suspension, 0.2%, is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis
Furthering cell therapy ambition across oncology and autoimmune diseases
Syngene has completed a payment of Rs. 158.2 crores on December 22, 2023 in addition to the initial payment of Rs. 395 crores made on December 1, 2023
The plant is yet to start commercial operations
World HRD Congress is a well-known international body of Management Studies
Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners
Subscribe To Our Newsletter & Stay Updated